nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
|
Brantley, Eileen |
|
2005 |
58 |
1 |
p. 62-72 |
artikel |
2 |
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro
|
Horton, Terzah M. |
|
2005 |
58 |
1 |
p. 13-23 |
artikel |
3 |
Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo
|
Guo, Chun-Bao |
|
2005 |
58 |
1 |
p. 40-49 |
artikel |
4 |
CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas
|
Kim, Jong Gwang |
|
2005 |
58 |
1 |
p. 35-39 |
artikel |
5 |
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
|
Schott, Anne F. |
|
2005 |
58 |
1 |
p. 129-135 |
artikel |
6 |
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein
|
Pan, Qiangrong |
|
2005 |
58 |
1 |
p. 99-106 |
artikel |
7 |
Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo
|
Tao, Lei |
|
2005 |
58 |
1 |
p. 24-34 |
artikel |
8 |
Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection
|
Gray, Tasha |
|
2005 |
58 |
1 |
p. 117-128 |
artikel |
9 |
5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice
|
Saif, Muhammad Wasif |
|
2005 |
58 |
1 |
p. 136-142 |
artikel |
10 |
Human breast cell lines exhibit functional α2-adrenoceptors
|
Vázquez, Stella Maris |
|
2005 |
58 |
1 |
p. 50-61 |
artikel |
11 |
Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment
|
Hooijberg, J. H. |
|
2005 |
58 |
1 |
p. 1-12 |
artikel |
12 |
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization
|
Rose, William C. |
|
2005 |
58 |
1 |
p. 73-85 |
artikel |
13 |
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors
|
Eder, Joseph P. |
|
2005 |
58 |
1 |
p. 107-116 |
artikel |
14 |
Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer
|
Mori, Kiyoshi |
|
2006 |
58 |
1 |
p. 86-90 |
artikel |
15 |
p53 Status does not affect photodynamic cell killing induced by hypericin
|
Lee, H. B. |
|
2005 |
58 |
1 |
p. 91-98 |
artikel |